2014年4月
Itraconazole prophylaxis for invasive Aspergillus infection in lung transplantation
TRANSPLANT INFECTIOUS DISEASE
- 巻
- 16
- 号
- 2
- 開始ページ
- 340
- 終了ページ
- 343
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1111/tid.12187
- 出版者・発行元
- WILEY-BLACKWELL
Invasive Aspergillus infection (IA) is a significant cause of morbidity in lung transplantation (LT). However, its optimal prophylaxis is unclear. We routinely administer itraconazole (ITCZ) prophylaxis to all patients undergoing LT. In this study, we retrospectively evaluated the duration of prophylaxis and risk factors of IA. Among 30 adult patients who underwent LT, 5 patients developed IA. All patients with IA stopped ITCZ treatment within 1year. At least 1year of ITCZ prophylaxis is essential for the prevention of IA. Cytomegalovirus infection, renal replacement therapy, and tracheotomy were risk factors for IA.
- リンク情報
- ID情報
-
- DOI : 10.1111/tid.12187
- ISSN : 1398-2273
- eISSN : 1399-3062
- Web of Science ID : WOS:000333969500022